Mary Kay Fenton
2015 - Achillion Pharmaceuticals
In 2015, Mary Kay Fenton earned a total compensation of $527.9K as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 69% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,452 |
|---|---|
| Salary | $360,140 |
| Other | $8,298 |
| Total | $527,890 |
Fenton received $360.1K in salary, accounting for 68% of the total pay in 2015.
Fenton also received $159.5K in non-equity incentive plan and $8.3K in other compensation.
Rankings
In 2015, Mary Kay Fenton's compensation ranked 10,620th out of 13,638 executives tracked by ExecPay. In other words, Fenton earned more than 22.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,620 out of 13,638 | 22nd |
Division Manufacturing | 4,048 out of 5,190 | 22nd |
Major group Chemicals And Allied Products | 1,487 out of 1,854 | 20th |
Industry group Drugs | 1,225 out of 1,528 | 20th |
Industry Pharmaceutical Preparations | 959 out of 1,182 | 19th |
Source: SEC filing on April 17, 2017.
Fenton's colleagues
We found four more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2015.
2015
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2015
David Apelian
Achillion Pharmaceuticals
Chief Medical Officer
2015
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2015
Gautam Shah
Achillion Pharmaceuticals